Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry

Cytometry Part B - Clinical Cytometry

Volumn 80 B, Issue 1, 2011, Pages 8-13

  Zhao, Meina ^a   Kanegane, Hirokazu ^a   Kobayashi, Chie ^b   Nakazawa, Yozo ^c   Ishii, Eizaburo ^d   Kasai, Mikio ^e   Terui, Kiminori ^f   Gocho, Yoshihiro ^g   Imai, Kohsuke ^h   Kiyasu, Junichi ⁱ   Nonoyama, Shigeaki ^h   Miyawaki, Toshio ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Ibaraki Children's Hospital   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGANO CHILDREN'S HOSPITAL   (Japan)

^e Hirosaki Municipal Hospital   (Japan)

^f HIROSAKI UNIVERSITY   (Japan)

^g NIPPON MEDICAL SCHOOL   (Japan)

^h NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

ⁱ KYUSHU UNIVERSITY   (Japan)

Author keywords

Flow cytometry; Genetic analysis; Hemophagocytic lymphohistiocytosis; SH2D1A; SLAM associated protein; X linked lymphoproliferative syndrome

Indexed keywords

ANTIBODY CONJUGATE; FLUORESCEIN ISOTHIOCYANATE; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CD8+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GENE MUTATION; GENETIC ANALYSIS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; INFANT; LYMPHOID CELL; LYMPHOPROLIFERATIVE DISEASE; MALE; NATURAL KILLER CELL; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCHOOL CHILD; X CHROMOSOME LINKED DISORDER;

ADOLESCENT; ADULT; BASE SEQUENCE; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FLOW CYTOMETRY; FRAMESHIFT MUTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; LYMPHOPROLIFERATIVE DISORDERS; MALE; POINT MUTATION; SEQUENCE DELETION; YOUNG ADULT;

EID: 78650843675     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20552     Document Type: Article

References (12)

1. Sumegi H, Huang D, Lanyi A, Davis JD, Seemayer TA, Maeda A, Klein G, Seri M, Wakiguchi H, Purtilo DT, Gross TG,. Correlation of mutations of the SH2D1A gene and Epstein Barr virus infection with clinical phenotype and outcome in X linked lymphoproliferative disease. Blood 2000; 96: 3118 - 3125.
2. Seemayer TA, Gross TG, Egeler RM, Pirruccello SJ, Davis JR, Kelly CM, Okano M, Lanyi A, Sumegi J,. X linked lymphoproliferative disease: Twenty five years after the discovery. Pediatr Res 1995; 38: 471 - 478.
3. Gross TG, Filipovich AH, Conley ME, Pracher E, Schmiegelow K, Verdirame JD, Vowels M, Williams LL, Seemayer TA,. Cure of X linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): Report from the XLP registry. Bone Marrow Transplant 1996; 17: 741 - 744.
4. Coffey AJ, Brooksbank RA, Brandau O, Oohashi T, Howell GR, Bye JM, Cahn AP, Durham J, Heath P, Wray P, Pavitt R, Wilkinson J, Leversha M, Huckle E, Shaw Smith CJ, Dunham A, Rhodes S, Schuster V, Porta G, Yin L, Serafini P, Sylla B, Zollo M, Franco B, Bolino A, Seri M, Lanyi A, Davis JR, Webster D, Harris A, Lenoir G, de St Basile G, Jones A, Behloradsky BH, Achatz H, Murken J, Fassler R, Sumegi J, Romeo G, Vaudin M, Ross MT, Meindl A, Bentley DR,. Host response to EBV infection in X linked lymphoproliferative disease results from mutations in an SH2 domain encoding gene. Nat Genet 1998; 20: 129 - 135.
5. Nichols KE, Harkin DP, Levitz S, Krainer M, Kolquist KA, Genovese C, Bernard A, Ferguson M, Zuo L, Snyder E, Buckler AJ, Wise C, Ashley J, Lovett M, Valentine MB, Look AT, Gerald W, Housman DE, Haber DA,. Inactivating mutations in an SH2 domain encoding gene in X linked lymphoproliferative syndrome. Proc Natl Acad Sci USA 1998; 95: 13765 - 13770.
6. Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, van Schaik S, Notarangelo L, Geha R, Roncarolo MG, Oettgen H, De Vries JE, Aversa G, Terhorst C,. The X linked lymphoproliferative disease gene product SAP regulates signals induced through the co receptor SLAM. Nature 1998; 395: 462 - 469.
7. Rigaud S, Fondanèche MC, Lambert N, Pasquier B, Mateo V, Soulas P, Galicier L, Le Deist F, Rieux Laucat F, Revy P, Fischer A, de Saint Basile G, Latour S,. XIAP deficiency in humans causes an X linked lymphoproliferative syndrome. Nature 2006; 444: 110 - 114.
8. Shinozaki K, Kanegane H, Matsukura H, Sumazaki R, Tsuchida M, Makita M, Kimoto Y, Kanai R, Tsumura K, Kondoh T, Moriuchi H, Miyawaki T,. Activation dependent T cell expression of the X linked lymphoproliferative disease gene product SLAM associated protein and its assessment for patient detection. Int Immunol 2002; 14: 1215 - 1223.
9. Bradford JA, Buller G, Suter M, Ignatius M, Beechem JM,. Fluorescence intensity multiplexing: Simultaneous seven marker, two color immunophenotyping using flow cytometry. Cytometry A 2004; 61A: 142 - 152.
10. Nagy N, Cerboni C, Mattsson K, Maeda A, Gogolák P, Sümegi J, Lányi A, Székely L, Carbone E, Klein G, Klein E,. SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines. Int J Cancer 2000; 88: 439 - 447.
11. Tabata Y, Vilanueva J, Lee SM, Zhang K, Kanegane H, Miyawaki T, Sumeji J, Fillipovich AH,. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X linked lymphoproliferative disease and their family members. Blood 2005; 105: 3066 - 3071.
12. Marsh RA, Villanueva J, Zhang K, Show AL, Su HC, Madden L, Mody R, Kitchen B, Marmer D, Jordan MB, Risma KA, Filipovich AH, Bleesing JJ,. A rapid flow cytometric screening test for X linked lymphoproliferative disease due to XIAP deficiency. Cytometry B Clin Cytometry 2009; 76B: 334 - 344.